Cargando…
Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
Critically ill patients with COVID-19 face a higher risk of disease progression and complications. The current standard of care includes supportive care measures and fluid management. The Recovery trial observed a reduction in all-cause, 28-day mortality (p<0.001) when patients with COVID-19 requ...
Autores principales: | Torres, Antoni, Cilloniz, Catia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106207/ https://www.ncbi.nlm.nih.gov/pubmed/35488828 http://dx.doi.org/10.37201/req/s01.13.2022 |
Ejemplares similares
-
Ventilation support in SARS-CoV-2 pneumonia. Strategy and indications
por: Gordo, Federico, et al.
Publicado: (2022) -
Respiratory consequences after COVID-19: outcome and treatment
por: Molina-Molina, María, et al.
Publicado: (2022) -
Immune treatment in COVID-19
por: Menéndez, Rosario, et al.
Publicado: (2022) -
Respiratory infections in Coronavirus disease 2019
por: del Pozo, Jose L.
Publicado: (2022) -
Thrombose und COVID-19
por: Tzaneva, Stanislava
Publicado: (2021)